Skip to main content
Equibles

Bruce Wendel

Board Member

ImmunityBio, Inc. (IBRX)

Chairman

GT Biopharma, Inc. (GTBP)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Bruce Wendel

Bruce Wendel is recorded as Board Member at ImmunityBio, Inc. (IBRX) and Chairman at GT Biopharma, Inc. (GTBP). ImmunityBio, Inc. reported in an 8-K filed December 15, 2025 that Bruce Wendel was appointed Board of Directors, effective December 12, 2025. GT Biopharma, Inc. reported in an 8-K filed May 13, 2025 that Bruce Wendel resigned as member of the Board and all committees thereof, effective May 7, 2025.

“On December 10, 2025, the board of directors (the “Board”) of ImmunityBio, Inc. (the “Company”) appointed Bruce Wendel to the Board, effective as of December 12, 2025 (the “Effective Date”), with a term expiring at the Company’s 2026 annual meeting of stockholders.”
ImmunityBio, Inc. Form 8-K, filed December 15, 2025 · Read the filing
“On May 7, 2025, Bruce Wendel resigned as a member of the Board and all committees thereof.”
GT Biopharma, Inc. Form 8-K, filed May 13, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at GT Biopharma, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at ImmunityBio, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.